Literature DB >> 28109651

Late onset Krabbe disease due to the new GALC p.Ala543Pro mutation, with intriguingly high residual GALC activity in vitro.

Inge Krägeloh-Mann1, Klaus Harzer2, Kevin Rostásy3, Stefanie Beck-Wödl4, Antje Bornemann5, Judith Böhringer1, Andrea Bevot1, Verena Beck1, Gisela Merkel1, Maria Pechan1.   

Abstract

BACKGROUND: Krabbe disease (KD) is an inherited leukodystrophy due to a defect in the GALC gene which encodes the lysosomal galactosylceramide β-galactosidase (GALC). About two thirds of patients show the early onset form of KD dominated by cerebral demyelination leading to death in early infancy. Late onset forms include a spectrum of late infantile, juvenile and adult clinical courses. The deficiency of GALC leads to a galactosylceramide lipidosis in which lysosomal storage phenomena are seen almost only at the ultrastructural level.
RESULTS: In a 4-year-old boy, the clinical suspicion of KD was high according to neurologic and neuroimaging findings. However, laboratory results were inconclusive; white blood cell GALC activity being at 23 to 25% of the normal level, and GALC genotyping revealing the new homozygous p.Ala543Pro variant which, ex silico, was of unclear significance. Studying a skin biopsy, cultured fibroblasts showed the GALC activity at 21 to 30% of the normal level; ultrastructurally, clearly KD-specific inclusions were seen in the eccrine sweat gland cells, confirming a KD diagnosis.
CONCLUSION: The high clinical suspicion combined with the morphologic evidence for KD predict that the p.Ala543Pro variant is pathogenic for (late onset) KD. A hypothesis linked to the proline in the mutant GALC may explain the in vitro effect with high residual GALC activity. This patient would not have been correctly diagnosed, despite the strong clinical criteria of KD, if the electron microscopic results had not been available. The detailed knowledge of neurologic and neuroimaging signs is important in diagnostically problematic KD patients in which also an electron microscopic approach can be crucial.
Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Galactosylceramide degradation; Late onset Krabbe disease; Mutation introducing proline; Residual GALC activity; Skin ultrastructure; Specific inclusions

Mesh:

Substances:

Year:  2017        PMID: 28109651     DOI: 10.1016/j.ejpn.2016.12.012

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  4 in total

1.  Selective Pyramidal Tract Involvement in Late-Onset Krabbe Disease.

Authors:  Shruthi N Michael; Priyanka Madaan; Prashant Jauhari; Biswaroop Chakrabarty; Atin Kumar; Sheffali Gulati
Journal:  Indian J Pediatr       Date:  2019-05-15       Impact factor: 1.967

2.  Hospitalization Burden and Incidence of Krabbe Disease.

Authors:  Gabrielle Ghabash; Jacob Wilkes; Bradley J Barney; Joshua L Bonkowsky
Journal:  J Child Neurol       Date:  2021-10-20       Impact factor: 1.987

3.  GALC mutations in Chinese patients with late-onset Krabbe disease: a case report.

Authors:  Shunzhi Zhuang; Lingen Kong; Caiming Li; Likun Chen; Tingting Zhang
Journal:  BMC Neurol       Date:  2019-06-11       Impact factor: 2.474

4.  Natural history of Krabbe disease - a nationwide study in Germany using clinical and MRI data.

Authors:  Sarah Isabel Krieg; Ingeborg Krägeloh-Mann; Samuel Groeschel; Stefanie Beck-Wödl; Ralf A Husain; Ludger Schöls; Christiane Kehrer
Journal:  Orphanet J Rare Dis       Date:  2020-09-10       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.